Skip to main content

Table 1 Summary of data arising from experiments utilizing 'omics' technologies.

From: Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithms

Study
(Compartment) 		I
(Plasma) 		II
(Plasma) 		III
(Plasma) 		IV
(Plasma) 		V
(Tissue) 		VIa
(Tissue) 		VIb
(Plasma) 		VIIa
(Tissue) 		VIIb
(Plasma)
Disease area Organ
Toxicity 		Cardio-vascular
Disease 		Infectious Disease Neuro-muscular Disease Organ Toxicity Organ Toxicity Organ Toxicity
Species Human Human Mouse Mouse Rat Rat Rat
Platforms
- GC/MS √ √ √     √   
- Lipid LC/MS √ √ √ √ √ √ √ √ √
- Polar LC/MS √ √ √ √ √ √ √ √ √
- Proteomics
(Mass Spectrometry) 		√ √ √ √ √    √ √
- Proteomics
(Multiplexed Immunoassay) 		  √        √
  1. The metabolomic platforms utilized in various studies include GC/MS (gas chromatography coupled with mass spectrometry), Lipid LC/MS (liquid chromatography coupled with mass spectrometry platform targeting lipids) and Polar LC/MS (liquid chromatography coupled with mass spectrometry platform targeting polar metabolites).
Back to article page

BMC Bioinformatics

ISSN: 1471-2105

Contact us